Abstract
Neurons are highly polarized cells, often with very long processes, which can comprise up to 95% of the cytoplasm. This raises the issue of transporting and turnover of proteins transport. In addition to fast axonal transport, axonal translation has been proposed to be responsible for producing at least some axonal proteins. In multiple experimental models, local synthesis of several proteins has been demonstrated in axons, growth cones, and nerve terminals. Multiple lines of evidence are consistent with the existence of axonal rRNAs, mRNAs, tRNAs, and micro RNAs and micro RNA regulatory proteins (RISC complex). Multiple signalling pathways, including mTOR, may regulate axonal translation. The origin of axonal RNAs is often attributed to transport from the neuronal soma, but evidence supporting cell-to-cell transport from Schwann cells to axons as a source of at least some axonal RNAs is emerging. This intercellular transport will be discussed in the context of normal and regenerative conditions.
Keywords: Axon, local translation, miRNAs, mRNAs, mTOR, transcriptome, UTR, β-actin mRNA, Alpha- and beta-tubulin, energy-filtered transmission EM, periaxoplasmic ribosomal plaques, retinal ganglion cells, immuno-EM
Current Chemical Biology
Title: The Axonal Transcriptome: RNA Localization and Function
Volume: 5 Issue: 2
Author(s): Lucia Canclini, Alejandra Kun, Aldo Calliari, John A. Mercer, Jose R. Sotelo and Jose R. Sotelo-Silveira
Affiliation:
Keywords: Axon, local translation, miRNAs, mRNAs, mTOR, transcriptome, UTR, β-actin mRNA, Alpha- and beta-tubulin, energy-filtered transmission EM, periaxoplasmic ribosomal plaques, retinal ganglion cells, immuno-EM
Abstract: Neurons are highly polarized cells, often with very long processes, which can comprise up to 95% of the cytoplasm. This raises the issue of transporting and turnover of proteins transport. In addition to fast axonal transport, axonal translation has been proposed to be responsible for producing at least some axonal proteins. In multiple experimental models, local synthesis of several proteins has been demonstrated in axons, growth cones, and nerve terminals. Multiple lines of evidence are consistent with the existence of axonal rRNAs, mRNAs, tRNAs, and micro RNAs and micro RNA regulatory proteins (RISC complex). Multiple signalling pathways, including mTOR, may regulate axonal translation. The origin of axonal RNAs is often attributed to transport from the neuronal soma, but evidence supporting cell-to-cell transport from Schwann cells to axons as a source of at least some axonal RNAs is emerging. This intercellular transport will be discussed in the context of normal and regenerative conditions.
Export Options
About this article
Cite this article as:
Canclini Lucia, Kun Alejandra, Calliari Aldo, A. Mercer John, R. Sotelo Jose and R. Sotelo-Silveira Jose, The Axonal Transcriptome: RNA Localization and Function, Current Chemical Biology 2011; 5 (2) . https://dx.doi.org/10.2174/2212796811105020099
DOI https://dx.doi.org/10.2174/2212796811105020099 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Virtual Screening of Potential Anti-fatigue Mechanism of Polygonati Rhizoma Based on Network Pharmacology
Combinatorial Chemistry & High Throughput Screening Concept of Comprehensive Treatment for Osteoarthritis (OA)
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Insights into the Role of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Health and Disease
Current Chemical Biology The Potential Roles of Metallothionein as a Therapeutic Target for Cerebral Ischemia and Retinal Diseases
Current Pharmaceutical Biotechnology Targeted Delivery of Montelukast for the Treatment of Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Molecular Mechanisms, Proteinopathies and Therapeutic Strategies in Neurodegenerative Disorders
Current Genomics Modelling Human Disease with Pluripotent Stem Cells
Current Gene Therapy Mitochondria-Targeted Antioxidants as a Therapeutic Strategy for Protecting Endothelium in Cardiovascular Diseases
Current Medicinal Chemistry Manipulation of Microglial Activation as a Therapeutic Strategy in Alzheimers Disease
Current Medicinal Chemistry Overlapping Molecular Signatures in Parkinson's Patient Leukocytes Before and After Treatment and in Mouse Model Brain Regions
CNS & Neurological Disorders - Drug Targets 2015 Update of Erectile Dysfunction Management Following Radical Prostatectomy: From Basic Research to Clinical Management
Current Pharmaceutical Design Effects of Early Maternal Separation on Biobehavioral and Neuropathological Markers of Alzheimer's Disease in Adult Male Rats
Current Alzheimer Research Impulse Control Disorders in Parkinson’s Disease: A Review
Current Psychiatry Reviews X-ray Crystallography and Computational Docking for the Detection and Development of Protein–Ligand Interactions
Current Medicinal Chemistry Cognitive Improvement by Photic Stimulation in a Mouse Model of Alzheimer’s Disease
Current Alzheimer Research Conformational Changes and Aggregation of Expanded Polyglutamine Proteins as Therapeutic Targets of the Polyglutamine Diseases: Exposed β-Sheet Hypothesis
Current Pharmaceutical Design T Cell-Activated Signaling Pathways and Locally Produced Cytokines as Potential Targets in Celiac Disease
Current Drug Targets Effect of Rehabilitative Exercise Training on Peripheral Muscle Remodelling in Patients with COPD: Targeting Beyond the Lungs
Current Drug Targets Modern Pathology: Protein Mis-Folding and Mis-Processing in Complex Disease
Current Protein & Peptide Science SIRT1 Promotes Neuronal Fortification in Neurodegenerative Diseases through Attenuation of Pathological Hallmarks and Enhancement of Cellular Lifespan
Current Neuropharmacology